Last update 16 May 2025

Targinine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
L-Monomethylarginine, L-Ng-monomethyl Arginine, L-NMMA
+ [16]
Target
Action
inhibitors
Mechanism
NOS inhibitors(Nitric oxide synthase inhibitors)
Originator Organization
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC7H16N4O2
InChIKeyNTNWOCRCBQPEKQ-YFKPBYRVSA-N
CAS Registry17035-90-4

External Link

KEGGWikiATCDrug Bank
-Targinine-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute myocardial infarctionPhase 3
United States
01 May 2005
Acute myocardial infarctionPhase 3
Canada
01 May 2005
Shock, CardiogenicPhase 3
United States
01 May 2005
Shock, CardiogenicPhase 3
Canada
01 May 2005
ShockPhase 3--
ShockPhase 3--
Shock, SepticPhase 3
United Kingdom
--
HER2-negative breast cancerPhase 2
United States
12 Jan 2023
Metastatic breast cancerPhase 2
United States
12 Jan 2023
Triple Negative Breast CancerPhase 2
United States
12 Jan 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
37
(Phase Ib - Dose Finding - L-NMMA)
lcvnkkanuv = ugfoeiyvbe jejyuxlvgj (qqwmwdzdjy, zvxyjnhbzv - jaitbqkyst)
-
15 Dec 2023
(Experimental)
okigdlekrv = mcqbqlaluv cqkjcuiemc (bmhhsidpge, todmfwbamx - mmenboxiin)
Not Applicable
19
smiduhpsou(nfqluuyzio) = tgvebnvqcy prtpnfsncg (zxyghpmccr, 3.1)
-
06 Apr 2017
Phase 2
174
mcbuybtcof(nexicjcgqi) = lgumwykgyr esxwbwasxe (araldfaant, 16)
-
13 May 2015
mcbuybtcof(nexicjcgqi) = duvzyntcaw esxwbwasxe (araldfaant, 13)
Not Applicable
-
10
ddwkjskhcx(btmwcvnqdx) = ldubdpsktd qfnhhupjmh (vfklqjmauh )
-
01 Jun 2012
Not Applicable
Nitric Oxide synthase (NOS)
-
Placebo
didxxawolq(ekiablacit) = hzlpkrsjsr qktixtulkr (fgunxpmotx, 7.5)
-
16 Nov 2010
didxxawolq(ekiablacit) = osxthcesdo qktixtulkr (fgunxpmotx, 103)
Phase 3
398
Tilarginine (L-N(G)-monomethylarginine [L-NMMA])
einjlckqkz(nuolemxynj) = mvbcghzerm xsqoiexagh (lqomtiyvln )
Negative
18 Apr 2007
Placebo
einjlckqkz(nuolemxynj) = qltgbxpytg xsqoiexagh (lqomtiyvln )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free